Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators

BenzingaJan 9 03:32

Shareholders Should Be Pleased With BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Price

Simply Wall StJan 9 01:37

Bernstein Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $90

Futu NewsJan 8 16:33 · Ratings

Bernstein Sticks to Its Buy Rating for BioMarin Pharmaceutical (BMRN)

TipRanksJan 8 14:45 · Ratings

Zacks.com Featured Highlights Include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical

Yahoo FinanceJan 7 18:18

Express News | Biomarin Pharmaceutical Inc : BofA Global Research Cuts Price Objective to $100 From $101

BreakingsJan 6 21:44